BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33649833)

  • 21. Targeting mTOR by CZ415 Suppresses Cell Proliferation and Promotes Apoptosis via Lipin-1 in Cervical Cancer In Vitro and In Vivo.
    Zhang J
    Reprod Sci; 2021 Feb; 28(2):524-531. PubMed ID: 32944878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of long non-coding RNA GHET1 suppresses cervical carcinoma in vitro and in vivo.
    Ling W; Yangchun X; Wei W; Qiang W
    Cancer Biomark; 2020; 28(1):21-32. PubMed ID: 32176622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circ-E2F3 promotes cervical cancer progression by inhibiting microRNA-296-5p and increasing STAT3 nuclear translocation.
    Cao X; Ma Q; Wang B; Qian Q; Xi Y
    Ann N Y Acad Sci; 2022 Jan; 1507(1):84-98. PubMed ID: 34468993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tripartite motif‑containing 14 regulates cell proliferation and apoptosis in cervical cancer via the Akt signaling pathway.
    Diao W; Zhu C; Guo Q; Cao Y; Song Y; Feng H; Li J; Xue X; Lu P
    Mol Med Rep; 2020 Dec; 22(6):5145-5154. PubMed ID: 33174608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation.
    Dong P; Xiong Y; Hanley SJB; Yue J; Watari H
    J Exp Clin Cancer Res; 2017 Oct; 36(1):150. PubMed ID: 29073938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOXD3‑AS1/miR‑128‑3p/LIMK1 axis regulates cervical cancer progression.
    Yang X; Du H; Bian W; Li Q; Sun H
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-204 Regulates Cell Proliferation and Invasion by Targeting EphB2 in Human Cervical Cancer.
    Duan S; Wu A; Chen Z; Yang Y; Liu L; Shu Q
    Oncol Res; 2018 Jun; 26(5):713-723. PubMed ID: 28800788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
    Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
    Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MUC16 facilitates cervical cancer progression via JAK2/STAT3 phosphorylation-mediated cyclooxygenase-2 expression.
    Shen H; Guo M; Wang L; Cui X
    Genes Genomics; 2020 Feb; 42(2):127-133. PubMed ID: 31736008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FOXP3‑induced LINC00885 promotes the proliferation and invasion of cervical cancer cells.
    Liu Y; Tu H; Zhang L; Xiong J; Li L
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer T cell cytotoxic activity in cervical cancer is facilitated by the LINC00240/microRNA-124-3p/STAT3/MICA axis.
    Zhang Y; Li X; Zhang J; Liang H
    Cancer Lett; 2020 Apr; 474():63-73. PubMed ID: 31904481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
    Liu X; Yang WT; Zheng PS
    Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-1258 promotes the apoptosis of cervical cancer cells by regulating the E2F1/P53 signaling pathway.
    Peng X; Zhang Y; Gao J; Cai C
    Exp Mol Pathol; 2020 Jun; 114():104368. PubMed ID: 31917289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
    Wang N; Zhou Y; Zheng L; Li H
    Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
    Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
    J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
    Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of protease-activated receptor-2 induces apoptosis in cervical cancer by inhibiting signal transducer and activator of transcription-3 signaling.
    Shanshan H; Lan X; Xia L; Huang W; Meifang Z; Ling Y
    J Int Med Res; 2019 Mar; 47(3):1330-1338. PubMed ID: 30700181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
    Wei L; Qin XP; Zhao XX; Wang W
    Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
    [No Abstract]   [Full Text] [Related]  

  • 39. The novel circular RNA circ-PGAP3 retards cervical cancer growth by regulating the miR-769-5p/p53 axis.
    Jun T; Chen W; Hailing C; Ning W; Qinxue C
    Hum Cell; 2021 May; 34(3):878-888. PubMed ID: 33591461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of DCK knockdown on proliferation, apoptosis and tumorigenicity in vivo of cervical cancer HeLa cells.
    Shang QY; Wu CS; Gao HR
    Cancer Gene Ther; 2017 Sep; 24(9):367-372. PubMed ID: 28820179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.